Respiratory
Explore our latest news, features and educational resources in this specialist area.
Updated NICE guideline on bronchiolitis in children – summary of key changes
NICE has issued a partial guideline update after reviewing the evidence on oxygen saturation thresholds for referral to hospital, admission, management and discharge. Quickly find out what's new with this summary.
NICE does not recomment treatment for progressive fibrosing interstitial lung diseases
NICE has issued draft guidance which does not recommend nintedanib for treating progressive fibrosing interstitial lung diseases, excluding idiopathic pulmonary fibrosis.
Three treatments accepted for use within NHS Scotland under the orphan medicine/ equivalent process
The treatments recommended are for chronic fibrosing interstitial lung diseases, mycosis fungoides and Sézary syndrome, and metastatic gastric cancer.
Enerzair® Breezhaler® recommended within NHS Wales
Indacaterol acetate/glycopyrronium bromide/mometasone furoate is recommended for the maintenance treatment of asthma in adults.
SMC accepts two asthma treatments
The treatments offer additional treatment choices of ICS/LABA/LAMA and ICS/LABA in a single inhaler.
